Vistin Pharma ASA: Change in oil derivative exposure

Written by Customer Service on . Posted in Public Companies.

Oslo, Norway, 28 February 2020
Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN), announces that the company has reduced its exposure to the spread between ICE low sulphur gasoil and Sing380.The changed exposure has been carried out by reducing the position in ICE low sulphur gasoil with 5,000MT in April and 25,000MT in December while keeping the exposure to the SING380 unchanged.The transaction has been carried out to reduce the remaining overall risk in the portfolio of oil derivatives under the current market conditions.The transaction resulted in a loss of approximately 46.5 million. 
                       
After the transactions, excluding the contracts that expire in February, the remaining positions are long in the spread between Gasoil versus Sing380 with 47,600MT and short on Sing380 with 30,000MT:As previously communicated, any changes to the volumes and exposure will be subsequently announced. *****For further information, please contact:Lars Christian Stugaard+47 47 63 05 22
LarsChristian@ferncliff.noThis information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.